• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Med Sci Atheroscler Dis . Hypertension, diabetes mellitus, and cerebrovascular disease predispose to a more severe outcome of COVID-19

tetano

Editor, Senior Moderator
Arch Med Sci Atheroscler Dis


. 2021 Apr 12;6:e30-e39.
doi: 10.5114/amsad.2021.105255. eCollection 2021.
Hypertension, diabetes mellitus, and cerebrovascular disease predispose to a more severe outcome of COVID-19


Kamleshun Ramphul[SUP] 1 [/SUP], Petras Lohana[SUP] 2 [/SUP], Yogeshwaree Ramphul[SUP] 3 [/SUP], Yun Park[SUP] 4 [/SUP], Stephanie Mejias[SUP] 5 [/SUP], Balkiranjit Kaur Dhillon[SUP] 6 [/SUP], Shaheen Sombans[SUP] 7 [/SUP], Renuka Verma[SUP] 8 [/SUP]



Affiliations

Abstract

Introduction: The world is currently facing the pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The total number of cases of coronavirus disease 2019 (COVID-19) is rising daily and no vaccine has yet been approved. While the pathophysiology behind the virus is still being studied, many possible several risk factors using small sample sizes have been found.
Material and methods: We conducted a pooled analysis using several databases such as Medline, Scopus, Wangfang, Web of Science, Research Square, medrxiv, and Google Scholar to identify studies reporting severe and non-severe groups of COVID-19 patients. The odds ratios as well as the 95% confidence intervals for hypertension, diabetes, and cerebrovascular disease leading to severe COVID-19 were calculated using R-software.
Results: Fifty-three articles were used for our analysis and they involved 30,935 confirmed cases of COVID-19 from several countries across the world. The odds ratio for severe COVID-19 in hypertensive patients, diabetics, and patients with a history of cerebrovascular disease was 2.58 (95% confidence interval (CI): 2.16-3.08, from 53 studies), 2.17 (95% CI: 1.72-2.74, from 44 studies), and 2.63 (95% CI: 1.80-3.85, from 25 studies), respectively.
Conclusions: Our analysis confirms that patients with hypertension, diabetes, or cerebrovascular disease are at a higher risk of a severe outcome of COVID-19. It is thus vital for physicians to identify the main risk factors for a severe outcome of this disease.

Keywords: COVID-19; SARS-CoV-2; cerebrovascular disease; coronavirus 2019; diabetes; hypertension; meta-analysis; pooled analysis; severity; stroke.
 
Back
Top Bottom